Related Experiment Video
Updated: Aug 5, 2026

A Murine Model of Pressure Overload-Induced Right Ventricular Hypertrophy and Failure by Pulmonary Trunk Banding
Published on: June 14, 2024
PRMT2 Aggravates Pressure Overload-induced Cardiac Remodeling by Promoting Endothelial Phenotypic Transition via
Xianwei Fan1, Xuejie Li1, Juan Hu1
1Department of Cardiology, Fuwai Central China Cardiovascular Hospital, Henan Cardiovascular Disease Center (Central China Subcenter of National Center for Cardiovascular Diseases), Central China Fuwai Hospital of Zhengzhou University, Henan Provincial Cardiovascular Hospital, Zhengzhou, P.R. China.
Protein arginine methyltransferase 2 (PRMT2) drives endothelial-to-mesenchymal transition during cardiac remodeling. Silencing PRMT2 in endothelial cells reduces cardiac fibrosis and hypertrophy, offering a potential therapeutic target for heart failure.
Area of Science:
- Cardiovascular Biology
- Epigenetics
- Cellular Biology
Background:
- Endothelial-to-mesenchymal transition (EndMT) contributes to cardiac remodeling under stress.
- Protein methylation, particularly arginine methylation, is increasingly recognized in regulating cellular transitions.
- The specific role of PRMT2 in endothelial phenotypic transition within cardiac remodeling is not well-defined.
Purpose of the Study:
- To investigate the role of protein arginine methyltransferase 2 (PRMT2) in endothelial phenotypic transition during cardiac remodeling.
- To elucidate the underlying molecular mechanisms by which PRMT2 influences cardiac pathological changes.
Main Methods:
- Utilized a transverse aortic constriction (TAC) mouse model to induce cardiac remodeling.
- Employed adeno-associated virus serotype 9 (AAV9) for endothelial-specific PRMT2 silencing in vivo.
- Conducted in vitro experiments using murine cardiac microvascular endothelial cells to assess PRMT2 function.
Main Results:
- PRMT2 expression increased in cardiac endothelial cells post-pressure overload.
- Endothelial-specific PRMT2 silencing attenuated cardiac hypertrophy, fibrosis, and EndMT in TAC mice.
- PRMT2 promoted EndMT via Snail1 monomethylation and activation of the Snail signaling pathway; Snail1 knockdown reversed PRMT2-induced effects.
Conclusions:
- PRMT2 acts as a critical epigenetic regulator of endothelial phenotypic transition in cardiac remodeling.
- PRMT2 inhibition presents a potential therapeutic strategy for mitigating heart failure progression.
Related Concept Videos
Cardiomyopathy IV: Restrictive Cardiomyopathy
Mitral Regurgitation I: Introduction
Heart Failure II: Pathophysiology
